Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AGILON HEALTH, INC.

(AGL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

SVB Leerink Adjusts agilon health's Price Target to $35 from $37, Keeps Outperform Rating

11/01/2021 | 08:20am EST


ę MT Newswires 2021
All news about AGILON HEALTH, INC.
01/10AGILON HEALTH, INC. : Regulation FD Disclosure (form 8-K)
AQ
01/06Wells Fargo Adjusts agilon Health Price Target to $31 From $44, Maintains Overweight Ra..
MT
01/05Castlight Health to Be Acquired by CD&R's Vera for $370 Million
DJ
01/04INSIDER SELL : Agilon Health
MT
2021INSIDER SELL : Agilon Health
MT
2021agilon health to Participate in 40th Annual J.P. Morgan Healthcare Conference
BU
2021ER LIGHT : How Patients Get Emergency Care at a Fraction of an ER Visit or Hospital Stay
PU
2021Deutsche Bank Adjusts Agilon Health's Price Target to $30 From $36, Maintains Buy Ratin..
MT
2021AGILON HEALTH : Recognizing and Valuing the Vital Role of Primary Care Doctors in our Comm..
PU
2021AGILON HEALTH : The Keys to Healthcare Sustainability for Seniors
PU
More news
Analyst Recommendations on AGILON HEALTH, INC.
More recommendations
Financials (USD)
Sales 2021 1 823 M - -
Net income 2021 -395 M - -
Net cash 2021 1 060 M - -
P/E ratio 2021 -19,2x
Yield 2021 -
Capitalization 7 720 M 7 720 M -
EV / Sales 2021 3,65x
EV / Sales 2022 2,57x
Nbr of Employees 550
Free-Float -
Chart AGILON HEALTH, INC.
Duration : Period :
agilon health, inc. Technical Analysis Chart | AGL | US00857U1079 | MarketScreener
Technical analysis trends AGILON HEALTH, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 19,61 $
Average target price 35,22 $
Spread / Average Target 79,6%
EPS Revisions
Managers and Directors
Steven J. Sell President, Chief Executive Officer & Director
Timothy S. Bensley Chief Financial Officer
Ronald A. Williams Chairman
Benjamin Kornitzer Chief Medical & Quality Officer
Girish Venkatachaliah Chief Technology Officer
Sector and Competitors